# BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS

> **NCT06597045** · — · ACTIVE_NOT_RECRUITING · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 60 (estimated)

## Conditions studied

- Cancer
- Cardiotoxicity
- Atherosclerotic Disease

## Interventions

- **DIAGNOSTIC_TEST:** PET/CT with 18-FDG

## Key facts

- **NCT ID:** NCT06597045
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2024-10-14
- **Final completion:** 2024-11-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597045, "BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06597045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*